News – Page 128 – Endpoints News

Ideaya aims to raise $263M; Immuneel extends Series A with $12M

10 months ago

The best-paying biotechs in the Bay Area, Boston and San Diego for 2023

10 months ago

How the world's biggest pharma and biotech companies paid their typical worker in 2023

10 months ago

Who pays the most (and least) in biopharma? We analyzed median pay at 177 companies

10 months ago

Updated: Flagship reels in $3.6B to create 25 new companies

10 months ago

Are 'next-gen' biotech acquirers experiencing their moment?

10 months ago

Arcutis tacks on atopic dermatitis approval for Zoryve cream

10 months ago

Amgen shelves early-stage bispecific T cell engager

10 months ago

Six big R&D questions for Pfizer as science chief Dolsten exits

10 months ago

Zevra to face FDA adcomm in August over previously rejected rare disease drug

10 months ago

Intellia to respond to lawsuit over in vivo therapy patents

10 months ago

UniQure trumpets mid-stage data for Huntington's disease gene therapy

10 months ago

Kymera's stock rises after derma investigation expands; Ligand buys Apeiron

10 months ago

Biopharma’s 20 highest-paid CEOs of 2023, earning $20M+ pay packages

10 months ago

Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches

10 months ago

FTC says PBMs ‘exercise vast control’ over healthcare, but stops short of calling for antitrust action

10 months ago

Pfizer CSO Mikael Dolsten to depart after 15 years leading drug giant's R&D

10 months ago

House speaker plans vote on Biosecure Act as part of China legislation push

10 months ago

Exclusive: Courier Health raises $16.5M Series A to help biopharma companies bring together patient data

10 months ago

Biovance debuts with €51M to lift up biotech scene in Portugal and southern Europe

10 months ago

German antibody company secures €63M for autoimmune disease program

10 months ago

Acquired biotech accuses Novartis of letting IL-15 asset 'wither on the vine'

10 months ago

Roche to reintroduce ocular implant two years after pulling it off the market

10 months ago

Gilead's HIV drug patent battle with CDC continues with government appeal

10 months ago

First page Previous page 125 126 127128129 130 131 Next page Last page